Condition
Hydrocephalus in adults, including normal pressure hydrocephalus
Too much spinal fluid builds up inside the brain. In older adults, normal pressure hydrocephalus can cause walking, thinking, and bladder problems that may improve with a shunt.
General information, not medical advice. In an emergency call 911. Full disclaimer
What it is
The brain makes a clear fluid called cerebrospinal fluid (CSF). It fills spaces inside the brain called ventricles. In hydrocephalus, too much fluid builds up, and the ventricles get bigger and press on the brain. [1]
Types in adults:
- Blocked flow (obstructive). Something blocks a narrow passage between the ventricles. See obstructive hydrocephalus. [4]
- Poor absorption (communicating). The fluid flows but is not absorbed well, for example after bleeding in the brain or meningitis. [4]
- Normal pressure hydrocephalus (NPH). A slow form of the communicating type, most common in older adults. The ventricles are large, but fluid pressure in the spine is normal. [4] When no cause is found, it is called idiopathic NPH. [3]
Symptoms
NPH usually starts slowly. Symptoms fall into 3 groups. [3]
- Walking. Trouble starting to walk. The feet can feel stuck to the floor. Balance is poor, and falls are common.
- Thinking. Forgetfulness, poor attention, and loss of interest.
- Bladder. Needing to pass urine often or urgently, or leaking urine.
Many people do not have all 3. Reports vary, and many find all 3 in about 60 out of 100. [5]
Other types of hydrocephalus in adults can cause headache, nausea, blurred or double vision, and sleepiness. [1]
How it is diagnosed
Why NPH is confused with other conditions. Parkinson's disease also slows walking, and Alzheimer's disease causes memory loss. Either can occur along with NPH. One clue: in Parkinson's disease, cues such as lines on the floor often help a person walk. In NPH they help little. [5]
Scans. A CT or MRI scan shows large ventricles. [3] Some MRI patterns, such as large ventricles with tight spaces at the top of the brain, make NPH likely. Their absence does not rule it out. [5] Large ventricles alone do not prove NPH. After a stroke or injury, the brain can shrink and make the ventricles look bigger. [1]
Tap test. A doctor removes some fluid with a needle in the lower back (spinal tap) and times walking before and after. [3] If symptoms improve, NPH is likely, and a shunt is likely to help. [5]
What the tap test cannot do. In reviews, the tap test missed about 42 out of 100 people who did well with a shunt. So no improvement does not rule out NPH. This is more common when symptoms have lasted a long time. [5]
Lumbar drain trial. A thin tube placed in the lower back drains fluid over a longer time. A good response to this drain or to repeated spinal taps raises the chance that a shunt will help. [6] It is not proven to predict shunt results better than the tap test. [5]
How it changes over time
Without treatment, NPH symptoms often get worse. This can lead to death. [1] [3] Early diagnosis and treatment improve the chance of recovery. [1]
Treatment choices
Monitoring and nonsurgical care. Not having surgery is a real option. Because a shunt has real risks, experts advise weighing the risks and benefits carefully. [6] No medicine has been proven to treat NPH. In a trial of 50 adults, acetazolamide did not improve walking better than a placebo (dummy pill) and caused more side effects. [7]
A shunt. The usual treatment is a ventriculoperitoneal (VP) shunt, a thin tube that drains extra fluid to the belly. [3]
How many people improve. Studies use different measures.
- Overall. In studies summarized by a Japanese guideline, about 63 to 84 out of 100 people improved in daily function at 1 year, and about 60 to 74 out of 100 at 3 to 6 years. [5]
- By symptom. Walking improved most often, in about 60 to 77 out of 100. Thinking improved in about 61 to 69 out of 100. Bladder control improved in about 52 out of 100. [5]
- Serious side effects. A 2015 US neurology guideline found that about 11 out of 100 people had one after a shunt. [6]
The placebo-controlled trial. In a 2025 trial, 99 people who improved with temporary fluid drainage got an adjustable shunt. In half, the valve was set to drain. In the other half, it was set to barely drain (placebo). Neither patients nor testers knew which. At 3 months, walking speed and balance improved more in the draining group. Memory and bladder scores did not differ clearly. [8]
In that trial, about 12 out of 100 in the draining group had bleeding on the brain's surface (subdural bleeding), compared with 2 out of 100 with placebo. Headaches when upright were also more common. [8] A 2026 review of 4 trials found clear benefit for walking and daily function, but a smaller or uncertain effect on thinking and bladder control. [9]
Who tends to do better. People with milder symptoms tend to do best. [3] People with fewer other serious illnesses also do better. [5] Older age alone may not lower the chance of improvement. [6]
For blocked flow, endoscopic third ventriculostomy (ETV) may replace a shunt. [1]
Questions to ask
- Do my scans and symptoms fit NPH, or could Parkinson's disease, Alzheimer's disease, or another cause explain them?
- Should I have a tap test or a lumbar drain trial, and what will you measure?
- If my test shows no change, what would you suggest next?
- Which of my symptoms is most likely to improve, and what are my risks from a shunt?
Sources
- Hydrocephalus. National Institute of Neurological Disorders and Stroke (NINDS). Published May 19, 2026. Open source
- ETV complications. Hydrocephalus Association. Published October 28, 2024. Open source
- Normal pressure hydrocephalus. MedlinePlus Medical Encyclopedia. US National Library of Medicine. Published January 27, 2026. Open source
- Hydrocephalus. American Association of Neurological Surgeons (AANS). Published April 8, 2024. Open source
- Nakajima M, Yamada S, Miyajima M, et al. Guidelines for management of idiopathic normal pressure hydrocephalus (third edition): endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo). 2021;61(2):63-97. Published January 15, 2021. Open source
- Halperin JJ, Kurlan R, Schwalb JM, Cusimano MD, Gronseth G, Gloss D. Practice guideline: idiopathic normal pressure hydrocephalus: response to shunting and predictors of response. Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2015;85(23):2063-2071. Published December 8, 2015. Open source
- Virhammar J, Fasth O, Ekblom M, et al. Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2026;25(6):550-559. Published June 1, 2026. Open source
- Luciano MG, Williams MA, Hamilton MG, et al. A randomized trial of shunting for idiopathic normal-pressure hydrocephalus. N Engl J Med. 2025;393(22):2198-2209. Published September 16, 2025. Open source
- Altaha M, Al Eid AJ, Aloraidh HH, et al. Cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus: a comprehensive meta-analysis with trial sequential analysis of randomized controlled trials. Neurol Sci. 2026;47(10). Published October 2, 2026. Open source